Cutaneous T-cell lymphoma of the mycosis fungoides type: report of case series
Main Article Content
Abstract
Cutaneous T-cell lymphomas represent a heterogeneous group of lymphoproliferative diseases characterized by skin infiltration by mature malignant T cells. More than 40% of cutaneous T-cell lymphomas are represented by mycosis fungoides. As they present non-specific cutaneous manifestations, they are often underdiagnosed. This article reports four cases of mycosis fungoides with different subtypes treated by a multidisciplinary team, highlighting aspects related to clinical heterogeneity and diagnostic, therapeutic and differential diagnostic challenges, followed by a brief review of the literature. The cases described demonstrate the heterogeneity of cutaneous and systemic clinical signs, with presentations that present a significant diagnostic challenge due to other diseases with similar manifestations, especially for non-specialist physicians in basic healthcare units. Mycosis fungoides continues to be a problematic diagnosis, as the cases described had varied presentations and numerous inconclusive biopsies. Low clinical suspicion and technical limitations in the analysis of biopsies of skin lesions were the main factors implicated. It is hoped that this series of cases will bring a better understanding of the diagnostic aspects of this disease.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Larocca C, Kupper T. Mycosis Fungoides and Sézary Syndrome: An Update. Hematol Oncol Clin North Am. 2019 Feb;33(1):103-120. doi: 10.1016/j.hoc.2018.09.001. PMID: 30497668; PMCID: PMC7147244.
Hodak E, Geskin L, Guenova E, Ortiz-Romero PL, Willemze R, Zheng J, Cowan R, Foss F, Mangas C, Querfeld C. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion. Am J Clin Dermatol. 2023 Jan;24(1):5-14. doi: 10.1007/s40257-022-00732-w. Epub 2022 Nov 18. Erratum in: Am J Clin Dermatol. 2023 May;24(3):493. PMID: 36399227; PMCID: PMC9673193.
Kaufman AE, Patel K, Goyal K, O'Leary D, Rubin N, Pearson D, Bohjanen K, Goyal A. Mycosis fungoides: developments in incidence, treatment and survival. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2288-2294. doi: 10.1111/jdv.16325. Epub 2020 May 24. PMID: 32141115; PMCID: PMC7733543.
Miyashiro D, Sanches JA. Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort. Int J Dermatol. 2022 Apr;61(4):442-454. doi: 10.1111/ijd.15865. Epub 2021 Aug 26. PMID: 34435672.
Hodak E, Amitay-Laish I. Mycosis fungoides: A great imitator. Clin Dermatol. 2019 May-Jun;37(3):255-267. doi: 10.1016/j.clindermatol.2019.01.004. Epub 2019 Jan 11. PMID: 31178107.
Kempf W, Mitteldorf C. Cutaneous T-cell lymphomas-An update 2021. Hematol Oncol. 2021 Jun;39 Suppl 1:46-51. doi: 10.1002/hon.2850. PMID: 34105822.
Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classifi-cation for primary cutaneous lymphomas. Blood. 2019 Apr 18;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268. Epub 2019 Jan 11. Erratum in: Blood. 2019 Sep 26;134(13):1112. PMID: 30635287; PMCID: PMC6473500.
Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013 Nov;149(11):1295-9. doi: 10.1001/jamadermatol.2013.5526. PMID: 24005876.
Cerroni L. Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018 Mar;37(1):2-10. doi: 10.12788/j.sder.2018.002. PMID: 29719014.
Lee H. Mycosis fungoides and Sézary syndrome. Blood Res. 2023 Apr 30;58(S1):66-82. doi: 10.5045/br.2023.2023023. PMID: 37105561; PMCID: PMC10133849.
Zic JA. Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma. Med Clin North Am. 2021 Jul;105(4):737-755. doi: 10.1016/j.mcna.2021.04.010. PMID: 34059248.
Valente M, Ribeiro K, Cruz T, Silva L, Ferreira A, Mayrink G, Silva D, Barbosa C, Drumond V, Utsch P. O desafio do diagnóstico clínico e histopatológico da micose fungoide. Hematol Transfus Cell Ther. 2021 Oct;43(1)
Pulitzer MP, Horna P, Almeida J. Sézary syndrome and mycosis fungoides: An overview, including the role of immuno-phenotyping. Cytometry B Clin Cytom. 2021 Mar;100(2):132-138. doi: 10.1002/cyto.b.21888. Epub 2020 Jun 9. PMID: 32516521; PMCID: PMC9306215.
Ryu HJ, Kim SI, Jang HO, Kim SH, Oh SH, Park S, Kim SK. Evaluation of the International Society for Cutaneous Lymphoma Algorithm for the Diagnosis of Early Mycosis Fungoides. Cells. 2021 Oct 15;10(10):2758. doi: 10.3390/cells10102758. PMID: 34685738; PMCID: PMC8534563.
Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova E, Gniadecki R, Hodak E, Jonak C, Klemke CD, Knobler R, Morrris S, Nicolay JP, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Wehkamp U, Whittaker S, Willemze R, Trautinger F. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023. Eur J Cancer. 2023 Dec;195:113343. doi: 10.1016/j.ejca.2023.113343. Epub 2023 Sep 18. PMID: 37890355.
Thomas TO, Agrawal P, Guitart J, Rosen ST, Rademaker AW, Querfeld C, Hayes JP, Kuzel TM, Mittal BB. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):747-53. doi: 10.1016/j.ijrobp.2012.05.034. Epub 2012 Jul 17. PMID: 22818412.
Dobos G, Lazaridou I, de Masson A. Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression. Cancers (Basel). 2023 Jan 25;15(3):746. doi: 10.3390/cancers15030746. PMID: 36765704; PMCID: PMC9913729.
Ryu HJ, Kim SI, Jang HO, Kim SH, Oh SH, Park S, Kim SK. Evaluation of the International Society for Cutaneous Lymphoma Algorithm for the Diagnosis of Early Mycosis Fungoides. Cells. 2021 Oct 15;10(10):2758. doi: 10.3390/cells10102758. PMID: 34685738; PMCID: PMC8534563.